Cystic fibrosis and literature review of Chinese pediatric cases

doi:10.3969/j.issn.1006-7795.2016.05.006

Abstract

CLC Number:

Wang Hao, Xu Baoping, Shen Kunling. Cystic fibrosis and literature review of Chinese pediatric cases[J]. Journal of Capital Medical University, 2016, 37(5): 588-592.

0
/ / Recommend

Add to citation manager EndNote|Reference Manager|ProCite|BibTeX|RefWorks

URL: https://journal03.magtech.org.cn/Jweb_sdykdxxb/EN/10.3969/j.issn.1006-7795.2016.05.006

https://journal03.magtech.org.cn/Jweb_sdykdxxb/EN/Y2016/V37/I5/588

[1] Davis P B. Cystic fibrosis since 1938[J]. Am J Respir Crit Care Med,2006,173(5):475-482.
[2] Paranjape S M, Mogayzel P J Jr. Cystic fibrosis[J]. Pediatr Rev, 2014, 35(5):194-205.
[3] Colombo C, Littlewood J. The implementation of standards of care in Europe:state of art[J]. J Cyst Fibros, 2011, 10 Suppl 2:S7-S15.
[4] Singh M, Rebordosa C, Bemholz J, et al. Epidemiology and genetics of cystic fibrosis in Asia:In preparation for the next-generation treatments[J]. Respirology, 2015, 20(8):1172-1181.
[5] Yamashiro Y, Shimizu T, Oguchi S, et al. The estimated incidence of cystic fibrosis in Japan[J]. J Pediatr Gastroenterol Nutr, 1997, 24(5):544-547.
[6] Riordan J R, Rommens J M, Kerem B, et al. Identification of the cystic fibrosis gene:cloning and characterization of complementary DNA[J]. Science,1989,245(4922):1066-1073.
[7] CFMD/CFTR1 Team. Cystic fibrosis mutation database[EB/OL].(2011-04-25)[2016-06-01] http://www.genet.sickkids.on.ca/team.html.
[8] Boyle M P, De Boeck K. A new era in the treatment of cystic fibrosis:correction of the underlying CFTR defect[J]. Lancet Respir Med, 2013,1(2):158-163.
[9] Farrell P M, Rosenstein B J, White T B, et al. Guidelines for diagnosis of cystic fibrosis in newborns through older adults:Cystic Fibrosis Foundation consensus report[J]. J Pediatr, 2008,153(2):S4-S14.
[10] Coakley J, Scott S, Mackay R, et al. Sweat testing for cystic fibrosis:standards of performance in Australasia[J]. Ann Clin Biochem, 2009, 46(Pt4):332-337.
[11] Wagener J S, Zemanick E T, Sontag M K. Newborn screening for cystic fibrosis[J]. Curr Opin Pediatr, 2012,24(3):329-335.
[12] Crossley J R, Elliott R B, Smith P A. Dried-blood spot screening for cystic fibrosis in the newborn[J]. Lancet, 1979,1(8114):472-474.
[13] Watson M S, Cutting G R, Desnick R J, et al. Cystic fibrosis population carrier screening:2004 revision of American College of Medical Genetics mutation panel[J]. Genet Med,2004,6(5):387-391.
[14] Flume P A, Robinson K A, O'Sullivan B P, et, al. Cystic fibrosis pulmonary guidelines:airway clearance therapies[J]. Respir Care, 2009, 54(4):522-537.
[15] Konstan M W, Ratjen F. Effect of dornase alfa on inflammation and lung function:potential role in the early treatment of cystic fibrosis[J]. J Cyst Fibros, 2012, 11(2):78-83.
[16] Treggiari M M, Retsch-Bogart G, Mayer-Hamblett N, et al. Comparative efficacy and safety of 4 randomized regimens to treat early Pseudomonas aeruginosa infection in children with cystic fibrosis[J]. Arch Pediatr Adolesc Med, 2011, 165(9):847-856.
[17] Cai Y, Chai D, Wang R, et al. Effectiveness and safety of macrolides in cystic fibrosis patients:a meta-analysis and systematic review[J]. J Antimicrob Chemother, 2011, 66(5):968-978.
[18] Sermet-Gaudelus I. Ivacaftor treatment in patients with cystic fibrosis and the G551D-CFTR mutation[J]. Eur Respir Rev,2013,22(127):66-71.
[19] 李楠,何冰,王广发,等. 囊性纤维化一例报告并文献复习[J]. 中华结核和呼吸杂志,2003,26(9):559-562.
[20] 王家伦, 谭郁彬. 囊性纤维化一例尸检报告[J]. 中华病理学杂志, 1983, 12(2):240.
[21] 陈坤华, 徐达, 刘作义. 小儿囊性纤维性变(附7例报告)[J]. 遗传与疾病, 1985, 2(4):257-259.
[22] 张晨美, 曹霞云. 囊性纤维化病2例报告[J]. 临床儿科杂志, 1993, 11(1):48.
[23] Wang M C, Shu S G, Chang S M, et al. Cystic fibrosis in two Chinese infants in Taiwan[J]. Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi, 1993, 34(4):314-321.
[24] Wang J Y, Hsieh K H, Chang M H, et al. Cystic fibrosis:report of a Chinese case with suggestive family history[J]. Taiwan Yi Xue Huai Za Zhi, 1987, 86(8):897-901.
[25] Wagner J A, Vassilakis A, Yee K, et al. Two novel mutation in a cystic fibrosis patient of Chinese origin[J]. Hum Genet, 1999,104(6):511-515.
[26] Boon W H. Cystic fibrosis in a Chinese girl[J]. J Singapore Paediatr Soc, 1975, 17(2):96-102.
[27] Crawford J, Labrinidis A, Garey W F, et al. A splincing mutation (1898+5G→T) in the CFTR gene causing cystic fibrosis[J]. Hum Mutant, 1995,5(1):101-102.
[28] Zielenski J, Markiewicz D, Lin S P, et al. Skipping of exon 12 as a consequence of a point mutation (1898+5G→T) in the cystic fibrosis transmembrane conductance regulator gene found in a consanguineous Chinese family[J]. Clin Genet, 1995, 47(3):125-132.
[29] Wu C L, Shu S G, Zielenski J, et al. Novel cystic fibrosis mutation (2215insG) in two adolescent Taiwanese siblings[J]. J Formos Med Assoc, 2000, 99(7):564-567.
[30] Alper O M, Shu S G, Lee M H, et al. Detection of Novel CFTR mutations in Taiwanese cystic fibrosis patients[J]. J Formos Med Assoc, 2003, 102(5):287-291.
[31] Chen H J, Lin S P, Lee H C, et al. Cystic fibrosis with homozygous R553X mutation in a Taiwanese child[J]. J Hum Genet, 2005, 50(12):674-678.
[32] 王犇, 杨丽. 囊性纤维化累及多系统一例[J]. 华西医学, 2012, 27(6):852-854.
[33] 刘金荣, 彭芸, 赵宇红,等. 中国儿童囊性纤维化二例临床特点及基因分析[J] 中华儿科杂志, 2012,50(11):829-833.
[34] Cheng Y, Ning G, Song B, et al. A Chinese girl with cystic fibrosis:a case report identified by sweat and genetic tests[J]. Chin Med J (Engl), 2012, 125(4):719.
[35] Xie Y, Huang X, Liang Y, et al. A new compound heterozygous CFTR mutation in a Chinese family with cystic fibrosis[J]. Clin Respir J, 2015,[Epub ahead of print].
[36] Liu Y, Wang L, Tian X, et al. Characterization of gene mutation and phenotypes of cystic fibrosis in Chinese patients[J]. Respirology, 2015, 20(2):312-318.
[37] 陈柏华, 张思仲, 杨元. 我国大陆首例DNA分析证实的囊性纤维化病及其突变分析[J]. 中华医学遗传学杂志, 1995,12(1):5-9.
[38] Li N, Pei P, Bu D F, et al. A novel CFTR mutation found in a Chinese patient with cystic fibrosis[J]. Chin Med J (Engl), 2006, 119(2):103-109.

Cystic fibrosis and literature review of Chinese pediatric cases

PDF

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	Li Ang, Huang Huijie, Yang Shiqing, Hou Xiaoling, Xiang Li. Analysis of characteristics of lung function trajectory in long-term treatment and management of children with asthma [J]. Journal of Capital Medical University, 2022, 43(6): 940-947.
[2]	Gao Man, Li Haiyan. Application research hotspot of traditional Chinese medicine informatics [J]. Journal of Capital Medical University, 2022, 43(4): 592-599.
[3]	Wang Hanyu, Zhang Yawen, Guo Xiaoyao, Cheng Hongfa, Zhang Qiuxia. Analysis on composition principles of prescriptions for cerebral small vessel disease based on Traditional Chinese Medicine inheritance support system [J]. Journal of Capital Medical University, 2022, 43(2): 254-259.
[4]	Xiang Xiaobo, Yan Lyubing, Zhou Yanmeng. Effect of Magnolia officinalis decoction on Candida albicans and its biofilm [J]. Journal of Capital Medical University, 2021, 42(5): 790-798.
[5]	Wu Hongbo, Li Manman, Lin Lili, Li Lihua. Analysis of 10-year death data of children aged 0-16 in single-center pediatric outpatient and emergency department [J]. Journal of Capital Medical University, 2021, 42(5): 852-856.
[6]	Li Xue, Ning Yanzhe, Jia Hongxiao. Identification and intervention strategies for anxiety with traditional Chinese medicine during COVID-19 pneumonia pandemics [J]. Journal of Capital Medical University, 2021, 42(3): 399-403.
[7]	Ma Jiajia, Yue Hongli, Wang Dexiang, Jin Xu, Han Ruquan. Effects of different doses of dexmedetomidine on postoperative agitation in children receiving craniotomy [J]. Journal of Capital Medical University, 2021, 42(3): 459-463.
[8]	Wang Zhenmin, Gong Jian. Study on the correlation between cerebrospinal fluid drainage and intracranial infection after craniotomy in children [J]. Journal of Capital Medical University, 2021, 42(2): 269-272.
[9]	Liu Miaomiao, Lyu Rui, Cheng Weiwei. Measurement of sagittal parameters of spine and pelvis in asymptomatic Han population [J]. Journal of Capital Medical University, 2021, 42(1): 105-110.
[10]	Yan Dan. Clinical bio-characteristic profiling: Evaluation of quality control and rational drug use of Chinese materia medica——Professor Yan Dan [J]. Journal of Capital Medical University, 2020, 41(5): 773-777.
[11]	Tong Yuru, Zhang Yifeng, Shen Siyu, Gao Wei. “Synthetic biology” innovation of active natural products of traditional Chinese medicine and new drug discovery——Professor Gao Wei [J]. Journal of Capital Medical University, 2020, 41(5): 783-787.
[12]	Han Xiaodi, Wang Mingze, Wang Shuo. The evolution from disastrous operation to minimal invasive surgery and brain reparation——Academician Zhao Jizong, the founder and pioneer of minimally invasive neurosurgery [J]. Journal of Capital Medical University, 2020, 41(5): 810-817.
[13]	Li Li, Yang Huasheng, Gou Chunyan, Wang Xiaojun, Luo Xiaolan, Zhang Jiaying, Li Hongyan, Li Tongzeng, Liang Lianchun, Li Xiuhui. Traditional Chinese medicine characteristics of 46 patients with COVID-19 [J]. Journal of Capital Medical University, 2020, 41(2): 155-160.
[14]	Zhang Peng, Yang Wei, Wang Kuiji, Tan Yi, Shang Xiaojuan, Shu Ning, Wang Xiang, Xu Shiwen, Sun Sanfeng, Zhao Xinyu, Yu Kun, Chen Luquan. A multi-center prospective case series study on the treatment of allergic rhinitis by acupuncture of sphenopalatine ganglion [J]. Journal of Capital Medical University, 2019, 40(6): 916-920.
[15]	Duan Chao, Wang Shengcai, Jin Mei, Zhang Dawei, Zhao Wen, Wang Xisi, Zhao Qian, Tai Jun, Zhang Jie, He Lejian, Zhang Jianguo, Ni Xin, Ma Xiaoli. Clinical features and outcome regarding head and neck non-rhabdomyosarcoma soft tissue sarcoma in children [J]. Journal of Capital Medical University, 2019, 40(6): 921-926.